Asia Pacific Allergy Diagnostics Market (2026-2031)
The Asia Pacific Allergy Diagnostics Market was valued at $417.5 Million in 2026 and projected to reach to $681.9 Million by 2031, representing a compound annual growth rate of 10.3%. Asia Pacific's allergy diagnostics market is positioned for substantial growth, driven by rising prevalence of allergic diseases, increasing healthcare awareness, and expanding diagnostic infrastructure across the region.
Asia Pacific Allergy Diagnostics Market Trends and Insights
- Latin America's market growth is driven by rising prevalence of allergic diseases, increasing healthcare awareness, and expanding diagnostic infrastructure across the region.
- Latin America represents a significant opportunity for allergy diagnostic providers, with demand accelerating due to improved access to testing technologies and growing patient populations seeking accurate diagnosis and treatment. Latin America's 10.3% compound annual growth rate outpaces the global average, reflecting strong regional momentum in healthcare modernization and allergy management.
- Latin America's market is characterized by increasing adoption of molecular and component-resolved diagnostics, alongside traditional immunoassay methods.
- By 2031, Latin America is expected to consolidate its position as a key growth market within the global allergy diagnostics landscape, supported by regulatory improvements and rising healthcare expenditure across major economies in the region..
Key Market Statistics
- CAGR (2026-2031) 10.3% CAGR
- Market Size, 2026 ~USD 417.5 Million
- Forecast, 2031 ~USD 681.9 Million
- Geography Asia Pacific
Asia Pacific Allergy Diagnostics Market Overview
Rapid Market Expansion :
Asia Pacific's allergy diagnostics market is growing at 10.3% CAGR, outpacing the global average of 9.6%, driven by increasing allergic disease prevalence and rising healthcare investments across the region.
China's Market Leadership :
China dominates Asia Pacific with a market size of $567.5 million, reflecting strong demand for advanced diagnostic solutions and expanding healthcare infrastructure in the world's most populous nation.
Emerging Market Opportunities :
India ($303.7M) and Japan ($308M) represent significant growth opportunities, with rising awareness of allergic conditions and increasing adoption of modern diagnostic technologies in both developed and developing healthcare systems.
Regional Growth Trajectory :
The Asia Pacific allergy diagnostics market is projected to grow from $417.5 million in 2026 to $681.9 million by 2031, reflecting strong regional demand and expanding diagnostic capabilities across major economies.
Asia Pacific Allergy Diagnostics Market Dynamics
- The market's 10.3% CAGR reflects strong demand from both developed economies like Japan and Australia and emerging markets like India and China, where healthcare modernization is accelerating. Key growth drivers include growing middle-class populations with increased healthcare spending, rising environmental pollution levels triggering allergic conditions, and adoption of advanced diagnostic technologies.
- Strategic investments in healthcare infrastructure, coupled with improving reimbursement policies and diagnostic accessibility, are expected to propel market expansion through 2031, making Asia Pacific a critical growth region for allergy diagnostics providers..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Key Takeaways
- Latin America's allergy diagnostics market is valued at $417.5 million in 2026, expanding to $681.9 million by 2031 at a 10.3% CAGR.
- Latin America's growth rate exceeds the global average, driven by rising allergic disease prevalence and healthcare infrastructure development.
- Latin America is witnessing increased adoption of advanced diagnostic technologies, including molecular and component-resolved testing methods.
- Latin America's market expansion is supported by regulatory improvements, rising healthcare spending, and growing patient awareness of allergy management.
Allergy Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | IN VITRO TESTS (Test Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 9.6% from 2026 to 2031 |
| Largest Segment | CONSUMABLES (Product & Service) |
| Market Size Base Year (Billions) | ~USD 6.81 (2026) |
| Revenue Forecast (Billions) | ~USD 10.77 (2031) |
| Segments Covered | Product & Service, Type, Test Type, Allergen, End User |
Asia Pacific Allergy Diagnostics Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product & Service
- Consumables
- Instruments
- Services
By Type
- Immunoassay Analyzers
- Luminometers
- Other In Vivo Tests
- Other Instruments
- Patch Tests
- Skin Prick Tests
By Test Type
- In Vitro Tests
- In Vivo Tests
By Allergen
- Drug Allergens
- Food Allergens
- Inhaled Allergens
- Other Allergens
By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Hospital-Based Laboratories
- Other End Users
Target Audience
- Diagnostic Device Manufacturers : Need Asia Pacific market data to identify expansion opportunities, assess market potential in high-growth countries like China and India, and develop region-specific product strategies for allergy diagnostics.
- Healthcare Providers & Hospitals : Require market insights to understand diagnostic demand trends, benchmark service offerings against regional competitors, and plan investments in allergy testing capabilities across Asia Pacific facilities.
- Investment & Private Equity Firms : Seek detailed market analysis to evaluate investment opportunities in Asia Pacific allergy diagnostics companies, assess growth potential, and identify acquisition targets in high-growth regional markets.
- Pharmaceutical & Biotech Companies : Need market intelligence to understand allergy diagnostic trends, identify partnership opportunities with diagnostic providers, and develop complementary treatment strategies for Asian markets.
- Healthcare Consultants & Analysts : Require comprehensive Asia Pacific market data to support client advisory services, competitive analysis, and strategic planning for healthcare organizations expanding diagnostic capabilities in the region.
Key Companies in the Asia Pacific Allergy Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| TECAN GROUP LTD. | Switzerland |
TECAN GROUP LTD.
TECAN GROUP LTD. is a Swiss life sciences company providing laboratory automation and diagnostic instruments.
Countries within Asia Pacific - compare and drill down
| Country | 2025 size (native) |
|---|---|
| China | USD 567.5 Million |
| Japan | USD 308 Million |
| India | USD 303.7 Million |
| South Korea | USD 117.5 Million |
| Australia | USD 155.3 Million |
| Rest Of Asia Pacific | USD 180.18 Million |
Country market size visualization
Reasons to Buy this Report
- Market Size & Growth Data : Access comprehensive market valuations for Asia Pacific ($417.5M in 2026) and country-level breakdowns including China ($567.5M), Japan ($308M), and India ($303.7M) with precise 10.3% CAGR projections.
- Competitive Landscape Intelligence : Understand market dynamics across Asia Pacific's diverse healthcare systems, identify leading diagnostic providers, and benchmark competitive positioning in the region's fastest-growing allergy diagnostics markets.
- Strategic Market Entry Planning : Leverage detailed country-specific insights to develop targeted market entry strategies, assess regulatory environments, and identify high-potential markets for allergy diagnostic products and services expansion.
- Investment & Partnership Opportunities : Identify emerging growth hotspots and investment opportunities in Asia Pacific's allergy diagnostics sector, with detailed market forecasts through 2031 to support M&A and partnership decisions.
- Demand Forecasting & Planning : Utilize precise market projections ($681.9M by 2031) and regional growth trends to forecast demand, optimize product portfolios, and allocate resources effectively across Asia Pacific markets.
Frequently asked questions
What is the current size of the allergy diagnostics market in Latin America?
The allergy diagnostics market in Latin America is valued at $417.5 million in 2026 and is projected to grow to $681.9 million by 2031.
What is the expected growth rate for Latin America's allergy diagnostics market?
Latin America's allergy diagnostics market is expected to grow at a compound annual growth rate (CAGR) of 10.3% from 2026 to 2031.
What factors are driving growth in Latin America's allergy diagnostics market?
Growth in Latin America is driven by rising allergic disease prevalence, increasing healthcare awareness, expanding diagnostic infrastructure, improved access to testing technologies, and growing healthcare expenditure across the region.
Which diagnostic technologies are gaining adoption in Latin America?
Latin America is experiencing increased adoption of molecular and component-resolved diagnostics alongside traditional immunoassay methods for allergy testing.
How does Latin America's market growth compare to global trends?
Latin America's 10.3% CAGR outpaces the global average of 9.6%, positioning the region as a high-growth market within the global allergy diagnostics landscape.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the global Allergy Diagnostic market. Exhaustive secondary research was done to collect information on the allergy diagnostic market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market sizes of the allergy diagnostic market's segments and subsegments.
Secondary Research
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ in-house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the allergy diagnostic market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, VPs/managing directors, marketing heads/directors and sales directors, marketing/sales managers, regional/area sales managers, export/import heads/managers, and other market-related personnel from various companies and organizations operating in the allergy diagnostic market. Primary sources from the demand side included vice presidents in hospitals & clinics, C-level executives, department heads, doctors/physicians, hospital supply management teams, clinic personnel, and laboratory technicians.
Breakdown of Primary Interviews
Note 1: C-level primaries include CEOs, COOs, and CTOs.
Note 2: Others include sales managers, marketing managers, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3 = <USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the allergy diagnostic market. These methods were also widely used to estimate the sizes of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The market was divided into four segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the market engineering process and arrive at precise statistics for all segments.
Approach to derive the market size and estimate market growth: Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of allergy diagnostic products. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
Allergy testing helps determine the substances causing a patient's allergy symptoms. Tests include skin tests, intradermal tests, challenge tests, blood tests, and patch tests. Allergists commonly conduct challenge tests, including food, inhalation, drug, and physical challenges. Blood tests are generally used when unsafe or unapplicable skin tests are required, such as when consuming certain medications or having a skin condition that may interfere with skin testing. Allergy tests, such as in vitro & in vivo tests, are performed to determine the cause, stage, prognosis, and treatment course for allergic diseases.
Key Stakeholders
- Allergy Diagnostic Reagents, Kits, and Instrument Manufacturers
- Allergy Diagnostic Vendors and Distributors
- Hospitals
- Diagnostic Laboratories
- Allergy Diagnostic Service Providers
- Academic Research Institutes
- Venture Capitalists and Investors
- Contract Research Organizations (CROs)
Report Objectives
- To describe, analyze, and forecast the allergy diagnostic market, by product & service, test type, allergen, end user, and region
- To describe and forecast the allergy diagnostic market for key regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries
- To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing the growth of the allergy diagnostic market
- To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s Five Forces, and prices pertaining to the market under study
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies in the allergy diagnostic market
- To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the allergy diagnostic market
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific allergy diagnostic market into Vietnam, New Zealand, and others
- Further breakdown of the Rest of Latin America allergy diagnostic market into Colombia, Chile, Ecuador, and others
- Further breakdown of the Rest of Europe allergy diagnostic market into Belgium, Russia, the Netherlands, Switzerland, and others
Get the Full Allergy Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Allergy Diagnostics Market.
- Canada Allergy Diagnostics Market
- US Allergy Diagnostics Market
- Germany Allergy Diagnostics Market
- UK Allergy Diagnostics Market
- France Allergy Diagnostics Market
- Italy Allergy Diagnostics Market
- Spain Allergy Diagnostics Market
- China Allergy Diagnostics Market
- Japan Allergy Diagnostics Market
- India Allergy Diagnostics Market
- South Korea Allergy Diagnostics Market
- Australia Allergy Diagnostics Market
- Brazil Allergy Diagnostics Market
- Mexico Allergy Diagnostics Market
- GCC Countries Allergy Diagnostics Market
- Rest Of Europe Allergy Diagnostics Market
- Rest Of Asia Pacific Allergy Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report